Results 161 to 170 of about 178,018,163 (293)

Explorative team learning as a catalyst for innovation and performance: Evidence from Vietnam's aviation sector. [PDF]

PLoS One
Ly HTM, Tučková Z, Pham NT, Nguyen TAV, Nguyen HX.   +4 more
europepmc   +1 more source

Evaluation of Dried Plasma Spot‐Based Quantification of Glial Fibrillary Acidic Protein as a Disease‐Associated Biomarker in Neuromyelitis Optica Spectrum Disorder

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the diagnostic accuracy of glial fibrillary acidic protein (GFAP) measured in dried plasma spots versus conventional plasma‐ and serum‐GFAP testing for assessment of disease severity in aquaporin‐4 immunoglobulin G–positive neuromyelitis optica spectrum disorder (AQP4‐IgG+ NMOSD).
Felix Wohlrab, Evelyn Alvarez, Roua Hamdi, Bingqing Zhang, Hayeun Ji, Niyati Jhaveri, Patrick Schindler, Pedro Sanchez, Pia S. Sperber, Tanja Schmitz‐Hübsch, Frederike C. Oertel, Nisa Vorasoot, Najib Kissani, Falko Böhringer, Jens Kuhle, Anne‐Katrin Pröbstel, Xiao‐Jun Ma, Péter Körtvelyessy, Patrick Waters, Friedemann Paul   +19 more
wiley   +1 more source

A Systemic Approach for Designing Open Innovation Value Networks [PDF]

The past two decades have seen a number of changes to the business and technological environment that have favored the rise of “open” collaborative innovation as alternative to the more traditional ”closed” models. The traditional view of innovation as a
Wegmann, Alain, Golnam, Arash, Regev, Gil, Hegarty, Aoife   +3 more
core   +1 more source

Collaboration in action: Protocol development across the MRC National Mouse Genetics Network. [PDF]

STAR Protoc
Bogani D, Reichenbach LF, Barlow JL, Blyth K.   +3 more
europepmc   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son, Inyoung Hwang, Sang Won Lee, Yun Kim   +3 more
wiley   +1 more source

Is Open Source about innovation? How interactions with the Open Source community impact on the innovative performances of entrepreneurial ventures [PDF]

Practitioners generally assert that collaboration with the Open Source software (OSS) community enables young software firms to achieve superior innovation performance. Nonetheless, to the best of our knowledge, scholars have never extensively speculated
Evila Piva, Francesco Rentocchini, Cristina Rossi Lamastra   +2 more
core  

Editorial: Soft computing and artificial intelligence techniques in decision making, management and engineering. [PDF]

Front Artif Intell
Leon-Castro E, Merigo JM, Blanco-Mesa F, Alfaro Garcia VG.   +3 more
europepmc   +1 more source

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

Editorial: State of the art in acute care surgery: application, innovation, and future perspectives. [PDF]

Front Surg
Pararas N.
europepmc   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source